Meet VitroScan!

1 November 2025

Nearly all of us know someone affected by cancer, and with every diagnosis come difficult treatment decisions.
At VitroScan, the team developed ChemoPredict: an ex vivo tumor testing service that helps doctors see which chemotherapy is most likely to work before treatment begins.

In this video, Willemijn Vader explains how ChemoPredict supports better treatment decisions, made possible thanks to the constructive collaboration with the Project Steering Committee: Jan Groen, Joris Schuurmans, Leo Price, Judith Kroep, and Michelle Meijer.
VitroScan also develops its tests in dialogue with patients, through Olijf and the Nederlandse Federatie van Kankerpatiëntenorganisaties (NFK), ensuring that innovation truly reflects patient needs.

Link to the video here